High-yield AAV production and improved manufacturability across multiple serotypes via a novel cell engineering platform
Conference Dates
February 4 - 8, 2024
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Kathy Ngo, Lawrence Chasin, and Larry Forman, "High-yield AAV production and improved manufacturability across multiple serotypes via a novel cell engineering platform" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/18
Poster 47 - Kathy Ngo.pdf (95 kB)
COinS